Venture Capital

Updated:

Voyage Ventures

CARTA VENTURES focuses on high-growth internet businesses and supports speedy, accurate business growth. It pursues mutual benefit with portfolio companies and...

Voyage Ventures logo

Voyage Ventures

CARTA VENTURES focuses on high-growth internet businesses and supports speedy, accurate business growth. It pursues mutual benefit with portfolio companies and CARTA HOLDINGS through both business collaboration and capital, and supports networking among portfolio companies.

General information

Firm type

Venture Capital

Year founded

2022

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

Tokyo, Japan

Principals

Hidenori Nagaoka

President & CEO, CARTA Ventures; Director, CARTA HOLDINGS

Shinsuke Usami

Founder, VOYAGE GROUP; Director, CARTA HOLDINGS

Sector focus

Enterprise SoftwareAI/MLFinTechBlockchain & Crypto

Frequently asked questions

How is Voyage Ventures connected to CARTA HOLDINGS and Dentsu?

CARTA VENTURES (formerly Voyage Ventures) is the investment division of CARTA HOLDINGS, a Tokyo Stock Exchange-listed digital services firm majority-owned by Dentsu Group. CARTA HOLDINGS formed in 2021 through the merger of VOYAGE GROUP and Carta Marketing. Dentsu's controlling stake provides institutional stability while Voyage Ventures maintains operational independence for startup deployment.

Who makes investment decisions at Voyage Ventures?

Hidenori Nagaoka serves as President and CEO of CARTA Ventures and sits on the board of CARTA HOLDINGS. Shinsuke Usami, founder of VOYAGE GROUP, also sits on the CARTA HOLDINGS board. The dual board-level oversight integrates investment activity with CARTA HOLDINGS' broader corporate strategy.

What types of companies does Voyage Ventures invest in?

The firm pursues a generalist venture strategy targeting early-stage and seed rounds, with an emphasis on enterprise software, artificial intelligence, fintech, and blockchain infrastructure. Nagaoka's external board roles at Pigeon Corporation and MedPeer, Inc. suggest additional operational interest in consumer health and digital healthcare platforms.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Tokyo Venture Capital profiles